Editas Medicine· @editasmed · X·· 2026-05-14AI 评分22
AI 导读
#NEWS：Editas Medicine 在美国基因与细胞治疗学会 2026 年年会上公布新临床前数据，展示 EDIT-401 作为高脂血症潜在治疗药物的进展。详情请阅读新闻稿：https://bit.ly/4dIHHve。 #ASGCT2026 #invivo
正文
#NEWS: Editas Medicine Reports New Preclinical Data Demonstrating Progress of EDIT-401 as Potential Treatment for Hyperlipidemia at the American Society of Gene and Cell Therapy 2026 Annual Meeting. Read the press release for details: https://bit.ly/4dIHHve.
#ASGCT2026 #invivo
来源：Editas Medicine · x.com